跳轉至內容
Merck
全部照片(1)

文件

A-007

Supelco

(+/-)-苯丙胺标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

同義詞:

(+/-)-苯丙胺标准液 溶液

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C9H13N
CAS號碼:
300-62-9
分子量：:
135.21
MDL號碼:
MFCD00056185
分類程式碼代碼:
41116107
PubChem物質ID:
329770569
NACRES:
NA.24

等級

certified reference material

品質等級

300

形狀

liquid

特點

SNAP-N-SPIKE®. SNAP-N-SHOOT®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal)

濃度

1.0 mg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

forensics and toxicology

格式

single component solution

儲存溫度

−20°C

SMILES 字串

CC(N)Cc1ccccc1

InChI

1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

InChI 密鑰

KWTSXDURSIMDCE-UHFFFAOYSA-N

尋找類似的產品？ 前往 產品比較指南

一般說明

苯丙胺，一种苯乙胺类兴奋剂，存在于如Adderall®、Vyvanse®和ProCentra®等ADHD治疗药物中。苯丙胺因其兴奋剂的作用，而作为性能增强剂和非法药物被娱乐性地使用。这款认证的加标溶液®适合通过LC-MS/MS或GC/MS用于尿液药物检测、运动检测、临床毒理学或法医分析应用。

應用

  • The research utilizes amphetamine as a model compound to validate new toxicological screening methods, improving postmortem diagnostic processes and forensic investigations (Franzin et al., 2024).
  • The study Investigates innovative sample preparation technologies for detecting amphetamines in biological matrices, pushing forward the capabilities in toxicological analysis and monitoring (Fabris et al., 2024).

法律資訊

Adderall is a registered trademark of Richwood Pharmaceutical Company, Inc.
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
ProCentra is a registered trademark of Outlook Pharmaceuticals, Inc.
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany
Vyvanse is a registered trademark of Shire, LLC

相關產品

產品號碼
描述
訂價

A-016

(±)-苯丙胺-d 11 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-050

6种他明类混标 CRM 溶液, 250 μg/mL each component in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-002

(±)-Amphetamine-d5 (deuterium label on ring) solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-005

(±)-苯丙胺-d5标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-008

S(+)-苯丙胺(右旋安非他明)标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-013

(±)-苯丙胺-d5标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-017

(±)-Amphetamine-d8 solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-018

(±)-Amphetamine-d8 solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-019

(±)-安非他明-D11标准液 CRM 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-044

(±)-苯丙胺-d 6标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-045

(±)-苯丙胺-d 6标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

A-049

R(-)-苯丙胺(左旋安非他命)标准液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

E-018

(±)-N-Ethylamphetamine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

L-026

Lisdexamfetamine dimesylate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

L-028

赖氨苯丙胺-D4二甲磺酸盐 溶液, 100 μg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

P-050

PMA hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®

A-212

(±)-Amphetamine-13C6 hydrochloride solution, 100 μg/mL in methanol ((as free base)), certified reference material, ampule of 1 mL, Cerilliant®

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes,Central nervous system

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 2

閃點（°F）

49.5 °F - closed cup

閃點（°C）

9.7 °C - closed cup

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Emily E Reichard et al.
Pharmaceutical research, 33(12), 2954-2966 (2016-11-04)
Methamphetamine (METH) abuse is a worldwide drug problem, yet no FDA-approved pharmacological treatments are available for METH abuse. Therefore, we produced an anti-METH single chain antibody fragment (scFv7F9Cys) as a pharmacological treatment for METH abuse. ScFv's have a short half-life
John F Bowyer et al.
BMC genomics, 14, 147-147 (2013-03-19)
The meninges (arachnoid and pial membranes) and associated vasculature (MAV) and choroid plexus are important in maintaining cerebrospinal fluid (CSF) generation and flow. MAV vasculature was previously observed to be adversely affected by environmentally-induced hyperthermia (EIH) and more so by
Constraints on regulatory options for putatively cognitive enhancing drugs.
Wayne Hall et al.
The American journal of bioethics : AJOB, 13(7), 35-37 (2013-06-19)
Tobacco: prohibition, coffee shops, or discouragement?
Yvette van der Eijk
The American journal of bioethics : AJOB, 13(7), 51-53 (2013-06-19)
Veljko Dubljević
The American journal of bioethics : AJOB, 13(7), 23-33 (2013-06-19)
This article analyzes appropriate public policies for enhancement use of two most important stimulant drugs: Ritalin (methylphenidate) and Adderall (mixed amphetamine salts). The author argues that appropriate regulation of cognition enhancement drugs cannot be a result of a general discussion
查看所有相關論文

條款

Accurate Biological Testing for Amphetamine and Methamphetamine Abuse Using Chiral HPLC and MS Detection

Optimized sample prep and chiral chromatography methods for the LC/MS analysis of these drug enantiomers in urine

Biological Testing for Amphetamine and Methamphetamine Abuse

In this study, optimized methods are presented for sample preparation and chiral chromatography for the LC/MS analysis of amphetamine and methamphetamine enantiomers in urine.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務